Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Zhongguo Zhong Yao Za Zhi ; 32(3): 224-6, 2007 Feb.
Article in Zh | MEDLINE | ID: mdl-17432144

ABSTRACT

OBJECTIVE: To establish a HPLC method for bufothionine in the skin of Bufo bufo gargarizans and Huachansu injection. METHOD: The samples were separated using a Lichrosob C18 column with CH3CN-H2O (10:90) as mobile phase. Flow rate was at 1.0 mL x min (-1) and the detection wavelength was at 225 nm. RESULT: The calibration curve of bufothionine was linear over the range of 0.0772-0.4632 microg and the average recovery was 99. 2%. The contents of bufothionine were fluctuated from 36.4-641.8 microg x g(-1) in the skin of Bufo bufo gargarizans and 22.47-33.16 microg x mL(-1) in Huachansu injection, respectively. CONCLUSION: The contents of bufothionine were greatly different between cultured and wild species. The method was suitable for the quality control of the skin of Bufo bufo gargarizans and its preparation.


Subject(s)
Materia Medica/chemistry , Phenothiazines/analysis , Skin/chemistry , Animals , Bufo bufo , China , Chromatography, High Pressure Liquid/instrumentation , Chromatography, High Pressure Liquid/methods , Injections , Materia Medica/administration & dosage , Materia Medica/isolation & purification , Quality Control , Reproducibility of Results
2.
Emerg Med Clin North Am ; 1(1): 87-100, 1983 Apr.
Article in English | MEDLINE | ID: mdl-6440775

ABSTRACT

Although most cases of Reye's syndrome that were initially reported were fatal, the overall mortality is now 20 to 30 per cent, with an even lower rate in some series. Improvement is due to both increased awareness of this disease and advances in care for the critically ill child. A good outcome depends on recognition of the early manifestations of the syndrome and appropriate initial therapy based on the stage of the disease.


Subject(s)
Reye Syndrome , Adolescent , Barbiturates/administration & dosage , Catheterization , Child , Child, Preschool , Humans , Intubation, Intratracheal , Mannitol/therapeutic use , Pancuronium/therapeutic use , Pentobarbital/therapeutic use , Phenothiazines/adverse effects , Prognosis , Reye Syndrome/chemically induced , Reye Syndrome/complications , Reye Syndrome/diagnosis , Reye Syndrome/drug therapy , Reye Syndrome/etiology , Reye Syndrome/physiopathology , Reye Syndrome/therapy , Salicylates/adverse effects
15.
Arch. argent. dermatol ; 53(1): 13-19, ene.-feb. 2003. ilus, tab
Article in Spanish | LILACS | ID: lil-337794

ABSTRACT

Se comunica una paciente de 44 años de edad que presentaba lesiones kaposiformes profusas, manifestación cutánea infrecuente del síndrome antifosfolípido. Se describen las características clínicas, los hallazgos de laboratorio, así como el tratamiento de esta enfermedad multisistémica


Subject(s)
Humans , Adult , Female , Antibodies, Antiphospholipid , Medicamentous Disease , Antiphospholipid Syndrome/diagnosis , Thrombosis , Contraceptives, Oral, Synthetic/adverse effects , Calcium Channel Blockers , Chlorothiazide , Chlorpromazine , Contraceptives, Oral , Contraceptives, Oral, Hormonal , Ethosuximide , Phenytoin/adverse effects , Hydralazine , Interferon-alpha , Penicillins , Phenothiazines , Procainamide , Pyrimethamine , Quinidine , Quinine , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/drug therapy , Streptomycin
SELECTION OF CITATIONS
SEARCH DETAIL